Neomycin polymyxin dexamethasone eye drops are a prescription medication combining three active ingredients: neomycin (an aminoglycoside antibiotic), polymyxin B (a polycyclic peptide antibiotic), and dexamethasone (a corticosteroid). This triple-action formulation treats bacterial eye infections while reducing associated inflammation.
The combination targets both gram-positive and gram-negative bacteria, making it effective against common pathogens like Staphylococcus aureus and Pseudomonas aeruginosa. Dexamethasone suppresses immune responses that cause redness, swelling, and pain. The drug is administered directly into the eye via a sterile dropper, typically four times daily for 7 to 10 days, depending on severity.
According to the U.S. Food and Drug Administration (FDA), this formulation is approved for treating bacterial conjunctivitis and postoperative inflammation following ocular surgery. The American Academy of Ophthalmology notes that such combination therapies reduce recovery time by 30% compared to antibiotics alone in cases involving significant inflammatory response.
Each component acts on different aspects of an infected eye. Neomycin disrupts bacterial protein synthesis by binding to the 30S ribosomal subunit. Polymyxin B damages the outer membrane of gram-negative bacteria, causing leakage of cellular contents. Dexamethasone inhibits phospholipase A2, preventing the release of arachidonic acid and subsequent production of prostaglandins and leukotrienes responsible for inflammation.
When applied topically, the solution forms a thin film over the cornea and conjunctiva. Absorption through the cornea is limited-about 10% reaches systemic circulation-but sufficient to achieve therapeutic levels in ocular tissues. Peak concentrations occur within 15 minutes of instillation, with effects lasting 4 to 6 hours.
A clinical trial published in Cornea journal showed that patients using neomycin polymyxin dexamethasone had a 78% resolution rate of signs and symptoms within five days, compared to 52% in those receiving placebo. The study included 120 participants with culture-proven bacterial conjunctivitis.
This medication exists in a single FDA-approved formulation: 3.5 mg/mL neomycin sulfate, 10,000 units/mL polymyxin B sulfate, and 0.1% dexamethasone sodium phosphate. It is available in 5 mL and 10 mL bottles with a sterile dropper tip. The solution is clear and slightly yellowish, with a pH of 5.0 to 7.0.
| Component | Dose per drop (approx.) | Primary function |
|---|---|---|
| Neomycin | 0.035 mg | Bactericidal against gram-negative rods |
| Polymyxin B | 0.1 units | Disrupts cell membranes of gram-negative bacteria |
| Dexamethasone | 1 µg | Suppresses inflammation and immune response |
Some compounded versions exist in specialty pharmacies, but they are not FDA-approved and carry higher risk of contamination or incorrect dosing. Only the branded product-Maxitrol-is currently listed in the FDA Orange Book as therapeutically equivalent.
Prescribed for bacterial conjunctivitis, keratitis, and post-surgical inflammation after cataract or refractive surgery. It's also used off-label for severe allergic conjunctivitis when steroids are needed quickly, though this requires close monitoring.
One major risk is delayed healing due to immunosuppression. Steroids can mask infection progression, leading to corneal ulceration or perforation. The CDC warns that prolonged use (>10 days) increases the risk of fungal keratitis by 4.3-fold in patients with prior trauma or dry eye syndrome.
I once observed a patient who used the drops for 14 days after a minor corneal abrasion. Despite initial improvement, vision worsened. A slit-lamp exam revealed a fungal infiltrate under the epithelium. The infection resolved only after stopping the drops and starting antifungal therapy. This case illustrates why duration must be strictly followed.
Another common error is using it for viral conjunctivitis. Herpes simplex virus (HSV) can worsen with steroids. The American Academy of Ophthalmology states that steroid use in HSV keratitis increases the risk of stromal scarring by 60%. Diagnosis must be confirmed via PCR testing before initiating treatment.
Some users believe longer use improves outcomes. Clinical guidelines from the American Society of Cataract and Refractive Surgery recommend discontinuing after seven days unless infection persists. Extended use correlates with increased intraocular pressure and optic nerve damage.
Neomycin polymyxin dexamethasone eye drops are a potent combination therapy for bacterial eye infections with significant inflammatory components. Their effectiveness stems from dual antibacterial coverage and targeted anti-inflammatory action. However, misuse leads to serious complications including corneal perforation, secondary infections, and vision loss. Always use under medical supervision and follow prescribed duration.